See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Corcept Therapeutics Incorporated (CORT) - free report >>
Broadwind Energy, Inc. (BWEN) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Corcept Therapeutics Incorporated (CORT) - free report >>
Broadwind Energy, Inc. (BWEN) - free report >>
Image: Bigstock
New Strong Sell Stocks for November 5th
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Alexander's, Inc. (ALX - Free Report) is a real estate investment trust which owns seven properties in the greater New York City metropolitan area. The Zacks Consensus Estimate for its current year earnings has been revised 9.4% downward over the last 30 days.
Broadwind, Inc. (BWEN - Free Report) is a provider of products to the energy, mining, and infrastructure sector customers in the United States. The Zacks Consensus Estimate for its current year earnings has been revised more than 100% downward over the last 30 days.
Corcept Therapeutics Incorporated (CORT - Free Report) is a discoverer and developer of drugs for the treatment of severe metabolic, oncologic, and psychiatric disorders. The Zacks Consensus Estimate for its current year earnings has been revised 1.2% downward over the last 30 days.
Eidos Therapeutics, Inc. is a clinical stage biopharmaceutical company. The Zacks Consensus Estimate for its current year earnings has been revised 2.5% downward over the last 30 days.
Ardmore Shipping Corporation (ASC - Free Report) is engaged in the seaborne transportation of petroleum products and chemicals. The Zacks Consensus Estimate for its current year earnings has been revised 47.8% downward over the last 30 days.
View the entire Zacks Rank #5 List.